Lyma Tanzania LTD(Kiwangwa Venom Biotech)

Kiwangwa Venom Biotech is a Tanzania-based bioeconomy company pioneering the development of Africa’s first integrated bee venom value chain. The company operates at the intersection of sustainable agriculture, biotechnology, and digital innovation, transforming traditional beekeeping into a high-value, science-driven industry.

The company specializes in the ethical production and processing of bee venom derived from Apis mellifera scutellata, supported by climate-resilient apiculture systems and standardized extraction protocols. Through the integration of field-based production and advanced laboratory validation, Kiwangwa Venom Biotech ensures high-quality bioactive compounds suitable for pharmaceutical and cosmetic applications.

A core component of the company’s model is the deployment of a digital traceability system, incorporating real-time hive monitoring, data analytics, and certification processes. This enables full transparency, quality assurance, and compliance with international market standards, particularly within European markets.

Kiwangwa Venom Biotech works closely with smallholder beekeepers, providing improved hives, technical training, and structured market access. This inclusive approach enhances rural livelihoods, promotes gender participation, and supports biodiversity conservation through sustainable pollinator management.

The company is currently leading the BIOVENOM-AFRICA initiative under Horizon Europe Cluster 6, in collaboration with international research institutions and innovation partners. The project focuses on developing a scalable, data-driven bioeconomy model that positions Africa as a strategic supplier of high-value bio-based products.

With a long-term vision to establish a Bee Venom Bank and expand into a diversified portfolio of bioactive bee products, Kiwangwa Venom Biotech aims to contribute to global health innovation while driving sustainable economic growth across rural communities.